Akihiro Shindo

10PUBLICATIONS
13CO-AUTHORS
Psycholinguistics (incl. speech production and comprehension)Autonomic nervous systemPeripheral nervous systemEpigenetics (incl. genome methylation and epigenomics)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Associations of Cognitive Impairment with Putative Glymphatic-Related Imaging Indices and Cortical Atrophy in Cerebral Amyloid Angiopathy.

|Apr 22, 2025
Alpha-1-acid glycoprotein as a potential serum biomarker for cerebral amyloid angiopathy.

Akisato Nishigaki, Hidehiro Ishikawa, Yamato Nishiguchi

|Oct 28, 2024
Effects of Goreisan in the Perioperative Period of Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Hiroyuki Kajikawa, Keita Matsuura, Yuichiro Ii

|Feb 26, 2022
High Mobility Group A1 Regulates Transcription Levels of Oligodendrocyte Marker Genes in Cultured Oligodendrocyte Precursor Cells.

Naohiro Egawa, Gen Hamanaka, Kelly K Chung

|Sep 25, 2021
Long-term MRI changes in a patient with Kelch-like protein 11-associated paraneoplastic neurological syndrome.

Hidehiro Ishikawa, Caleigh Mandel-Brehm, Akihiro Shindo

|Jul 01, 2021
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.

Takayuki Kondo, Haruhiko Banno, Taro Okunomiya

Pageof 2

Frequent Collaborators

4 joint publications

Hidehiro Ishikawa

2 joint publications

Yuichiro Ii

1 joint publications

Akitaka Yamamoto

1 joint publications

Hirofumi Matsuyama